VALOMINDO
Modified-release tablet, 80mg + 1.5mg
RxActive license
Active substance (INN)
indapamidevalsartan
Pharmaceutical form
Pharmaceutical formModified-release tablet
Strength80mg + 1.5mg
PackagingUkupno 30 tableta sa modofikovanim oslobađanjem u blisteru (3x10) u kartonskoj kutiji
ManufacturerKrka d.d., Slovenia
Therapeutic groupCardiovascular system (C09DA03)
Marketing authorization holderDIO STRANOG DRUŠTVA "KRKA D.D. NOVO MESTO" SLOVENIJA - PREDSTAVNIŠTVO PODGORICA
Authorization dateAugust 1, 2025
Analogs in Montenegro
20Other medicines with the same active substance
AMLEWELRx
Tablet, 2mg + 5mg + 0.625mgAMLEWELRx
Tablet, 8mg + 10mg + 2.5mgAMLEWELRx
Tablet, 8mg + 5mg + 2.5mgAMLEWELRx
Tablet, 4mg + 10mg + 1.25mgAMLEWELRx
Tablet, 4mg + 5mg + 1.25mgAMLEWELNEORx
Tablet, 10mg + 5mg + 2.5mgAMLEWELNEORx
Tablet, 10mg + 10mg + 2.5mgAMLEWELNEORx
Tablet, 5mg + 5mg + 1.25mgCO-DIOVANRx
Film-coated tablet, 80mg + 12.5mgDIOVANRx
Film-coated tablet, 40mgDIOVANRx
Film-coated tablet, 80mgENTRESTORx
Film-coated tablet, 26mg + 24mgENTRESTORx
Film-coated tablet, 51mg + 49mgENTRESTORx
Granules in capsules for opening, 16mg/15mgENTRESTORx
Film-coated tablet, 103mg + 97mgENTRESTORx
Granules in capsules for opening, 6mg/6mgFLIRKANORx
Film-coated tablet, 320mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 25mgSource: CInMED register